Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Asset disposition
Inv. presentation
Quarterly results
Director comp.
Director departure
Appointed director

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 252 shares @ $0.8904, valued at $224.4
10/03/2023 4 Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 90 shares @ $0.8904, valued at $80.1
10/03/2023 4 Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 2,239 shares @ $0.8904, valued at $2k
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/05/2023 4 Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 252 shares @ $1.2, valued at $302.4
07/05/2023 4 Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 90 shares @ $1.2, valued at $108
07/05/2023 4 Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 2,239 shares @ $1.2, valued at $2.7k
06/01/2023 4 Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 252 shares @ $1.21, valued at $304.9
06/01/2023 4 Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 90 shares @ $1.21, valued at $108.9
06/01/2023 4 Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 2,239 shares @ $1.21, valued at $2.7k
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2023 4 Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 252 shares @ $1.61, valued at $405.7
04/04/2023 4 Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 90 shares @ $1.61, valued at $144.9
04/04/2023 4 Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 2,239 shares @ $1.61, valued at $3.6k
03/24/2023 4 Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Sold 2,122 shares @ $1.6048, valued at $3.4k
Sold 11,667 shares @ $1.5085, valued at $17.6k
Sold 12,711 shares @ $1.502, valued at $19.1k
03/20/2023 4 MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Granted 20,576 shares @ $0
Granted 18,927 options to buy @ $1.62, valued at $30.7k
03/20/2023 4 BUCKMAN PAUL (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Granted 20,576 shares @ $0
Granted 18,927 options to buy @ $1.62, valued at $30.7k
03/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/07/2023 4 Mertens Steve (Chief Technology Officer) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 6,054 shares @ $1.47, valued at $8.9k
02/07/2023 4 Christianson Mark (Business Development Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 2,175 shares @ $1.47, valued at $3.2k
02/07/2023 4 Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Paid exercise price by delivering 53,750 shares @ $1.47, valued at $79k
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Granted 29,240 shares @ $0
Granted 29,230 options to buy @ $1.14, valued at $33.3k
06/02/2022 4 BUCKMAN PAUL (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Granted 29,240 shares @ $0
Granted 29,230 options to buy @ $1.14, valued at $33.3k
06/02/2022 4 Andrle Edward (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Granted 29,240 shares @ $0
Granted 29,230 options to buy @ $1.14, valued at $33.3k
05/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/04/2022 4 Rosa David A (CEO and President) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp
Txns: Granted 250,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy